Former Chief Development Officer · Viking Therapeutics, Inc. (VKTX)

Hiroko Masamune

A named executive officer of Viking Therapeutics in every fiscal year CompBrief holds from FY2018 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$906,073

Salary $233,332Stock awards $323,416

FY2018: $992,924

2nd of 2 named executive officers at Viking Therapeutics by FY2019 total.

2 named officers on file for Viking Therapeutics, FY2019

Hiroko Masamune’s pay file — $29

  • 2 fiscal years of pay, line by line
  • VKTX’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Viking Therapeutics’s whole pay program stands against its peers

  • Viking Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VKTX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 6, 2020 (DEF 14A).

Free

Get Hiroko Masamune’s full pay file as a PDF — free

More than this page: up to 10 years of Hiroko’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Hiroko Masamune compensation by year

Viking Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Viking Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019
Salary$302,726$233,332
Bonus$0$0
Stock awards$188,850$323,416
Option awards$395,348$349,325
Non-equity incentive$106,000$0
Pension and deferred compensation$0$0
All other$0$0
Total$992,924$906,073

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Viking Therapeutics, Inc. DEF 14A filed April 6, 2020, accession 0001564590-20-015522, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Viking Therapeutics, Inc. filed document, accession 0001564590-20-015522. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2020.

$993K
$906K
FY18
FY19
SalaryNon-equity incentiveStock awardsOption awards

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
PSU15,000$142,350—
PSU10,000$46,500—
Option42,000—$9.49
Option13,500—$1.08
Option30,000—$1.23
Option9,000—$1.26
Option35,000—$4.65
Option9,800—$2.15

Per the Outstanding Equity Awards at Fiscal Year-End table in Viking Therapeutics, Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Viking Therapeutics’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Brian LianChief Executive Officer$3,512,119
Hiroko Masamune · this pageFormer Chief Development Officer$906,073

The full Viking Therapeutics compensation record

free company brief

This page is one person within Viking Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Viking Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Hiroko Masamune's compensation dossier · One-time report. No refunds.